Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
about
Intraventricular antibiotics for bacterial meningitis in neonatesIntraventricular antibiotics for bacterial meningitis in neonatesComparison of ceftriaxone and ampicillin plus chloramphenicol for the therapy of acute bacterial meningitisCorrelation of in vitro time-kill curves and kinetics of bacterial killing in cerebrospinal fluid during ceftriaxone therapy of experimental Escherichia coli meningitisWhat preclinical data are needed to justify once-daily therapy?Pharmacokinetics and bacteriological efficacies of apalcillin and cefpiramide in experimental pneumococcal meningitisForecasting cephalosporin and monobactam antibiotic half-lives in humans from data collected in laboratory animals.Influence of four modes of administration on penetration of aztreonam, cefuroxime, and ampicillin into interstitial fluid and fibrin clots and on in vivo efficacy against Haemophilus influenzae.Pharmacokinetics and cerebrospinal fluid bactericidal activity of ceftriaxone in the treatment of pediatric patients with bacterial meningitis.Ceftriaxone diffusion into cerebrospinal fluid of children with meningitis.Comparison of ceftriaxone and traditional therapy of bacterial meningitis.Cephalosporins in adult meningitis.Pharmacokinetics and tissue concentrations of cefuroxime.Evaluation of piperacillin-tazobactam in experimental meningitis caused by a beta-lactamase-producing strain of K1-positive Escherichia coli.Pharmacokinetics and bacteriological efficacy of ticarcillin-clavulanic acid (timentin) in experimental Escherichia coli K-1 and Haemophilus influenzae type b meningitis.Antimicrobial therapy of experimental meningitis caused by Streptococcus pneumoniae strains with different susceptibilities to penicillin.New cephalosporins cefotaxime, cefpimizole, BMY 28142, and HR 810 in experimental pneumococcal meningitis in rabbits.Ceftriaxone: a beta-lactamase-stable, broad-spectrum cephalosporin with an extended half-life.Aztreonam therapy in experimental meningitis due to Haemophilus influenzae type b and Escherichia coli K1.Pharmacokinetics and antibacterial efficacy of cefpirome (HR 810) in experimental Escherichia coli and Haemophilus influenzae type b meningitis.Use of ampicillin-sulbactam for treatment of experimental meningitis caused by a beta-lactamase-producing strain of Escherichia coli K-1.Rationale for optimal dosing of beta-lactam antibiotics in therapy for bacterial meningitis.Once-daily administration of ceftriaxone in the treatment of meningitis and other serious infections in children.Cefuroxime treatment of bacterial meningitis in infants and children.Pharmacokinetics and bacteriological effect of ceftazidime in experimental Streptococcus pneumoniae, Haemophilus influenzae, and Escherichia coli meningitis.Pharmacokinetics and bacteriological efficacy of mezlocillin in experimental Escherichia coli and Listeria monocytogenes meningitis.Points: Treatment of bacterial meningitis.
P2860
Q24245841-F70D3F7F-A1E7-4EB6-809A-7A1D1CCAF911Q24247793-1C5A98AD-AEF2-4D68-A1E9-3C223BADEFD8Q30451305-68EE080E-A41A-465A-BD1E-371257AC34E5Q30451339-58BC245D-3922-4E8C-AC93-CD0C7BF1C386Q30899947-AF8A05EF-BF53-45C8-B997-8FE628713A7BQ35640164-EF69E13A-AD05-4655-9EA2-CB29F786721CQ35645087-BD1CA450-F0C1-44AB-9FAA-D9508DE27D5EQ35646823-B8610DD0-58D9-44FE-9603-215DF6E41C84Q35718258-84DB3266-2240-4519-AF6E-EBA4423CA27FQ35739719-BFD23192-2FEF-4A0A-BA83-BD0B705CD6BCQ35756153-D910C49F-DD62-47C3-BA5D-8389B9E70095Q35876822-4054CBE3-16FF-4268-A4A8-3D644BFEE063Q37782711-67A4FDEE-935E-4FDB-BCE2-80448198744EQ39815796-39229BBF-4BE6-4556-89D4-7345A0B6E4ACQ39828641-9C9ED3D0-8747-4D51-B568-F2AA6DC23D0FQ39833730-6DCC294D-538D-4297-9252-76BB95B6D7FAQ39833922-2BB1D73D-D3CF-4B6B-B8DF-F45C4EE6802FQ39835731-55DAE8A2-CB19-4031-BE13-6D182C3B7AB0Q39849756-BB9C5E91-1EBA-41AC-8854-64E269E2EC11Q40085768-23E08F07-92CE-49F9-BD75-D29439A0A0EEQ40087640-7D397B70-15B9-42A4-83F3-B8642DE75CA0Q40200463-ED2C22AA-2061-439C-A70A-F4B5BAE6D4BEQ40833427-3D9C3293-74E2-407B-BD91-287DCBBBDA5AQ42079584-4FE16BDE-5CFF-436E-8155-BF398DCE9A28Q42129227-FA4EA47E-CC7D-487C-9723-6A86A4F2572AQ42929829-E721F33F-1317-459C-9919-8BE10149F052Q45784358-45BF2F3B-738A-4EF5-B0CF-9F661B82175F
P2860
Pharmacokinetics and bacteriological efficacy of cefoperazone, ceftriaxone, and moxalactam in experimental Streptococcus pneumoniae and Haemophilus influenzae meningitis.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Pharmacokinetics and bacteriol ...... ophilus influenzae meningitis.
@en
Pharmacokinetics and bacteriol ...... ophilus influenzae meningitis.
@nl
type
label
Pharmacokinetics and bacteriol ...... ophilus influenzae meningitis.
@en
Pharmacokinetics and bacteriol ...... ophilus influenzae meningitis.
@nl
prefLabel
Pharmacokinetics and bacteriol ...... ophilus influenzae meningitis.
@en
Pharmacokinetics and bacteriol ...... ophilus influenzae meningitis.
@nl
P2093
P2860
P356
P1476
Pharmacokinetics and bacteriol ...... ophilus influenzae meningitis.
@en
P2093
McCracken GH Jr
P2860
P304
P356
10.1128/AAC.21.2.262
P407
P577
1982-02-01T00:00:00Z